-
Signature
-
/s/ Josh Samples, Attorney-in-Fact
-
Stock symbol
-
AFRM
-
Transactions as of
-
Nov 18, 2024
-
Transactions value $
-
-$6,680,534
-
Form type
-
4
-
Date filed
-
11/20/2024, 06:03 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
AFRM |
Class A Common Stock |
Options Exercise |
$204K |
+100K |
+62.72% |
$2.04 |
259K |
Nov 18, 2024 |
Direct |
F1 |
transaction |
AFRM |
Class A Common Stock |
Sale |
-$6.2M |
-100K |
-38.54% |
$62.00 |
159K |
Nov 18, 2024 |
Direct |
F1 |
transaction |
AFRM |
Class A Common Stock |
Gift |
$0 |
-4K |
-0.46% |
$0.00 |
868K |
Nov 18, 2024 |
Michalek 2007 Trust dated March 21, 2007 |
F2 |
transaction |
AFRM |
Class A Common Stock |
Options Exercise |
$22.5K |
+11K |
+6.93% |
$2.04 |
170K |
Nov 19, 2024 |
Direct |
F1 |
transaction |
AFRM |
Class A Common Stock |
Sale |
-$707K |
-11K |
-6.48% |
$64.00 |
159K |
Nov 19, 2024 |
Direct |
F1, F3 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
AFRM |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-100K |
-50% |
$0.00 |
100K |
Nov 18, 2024 |
Class A Common Stock |
100K |
$2.04 |
Direct |
F1, F4 |
transaction |
AFRM |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-11K |
-11.05% |
$0.00 |
89K |
Nov 19, 2024 |
Class A Common Stock |
11K |
$2.04 |
Direct |
F1, F4 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: